A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer

Author:

O’Donnell Michael A.1,Singh Sharwan2,Sood Rajeev3,Amlani Jitendra4,Krishnamoorthy H.5,Shukla Ketan6,Mohanty Nayan7,Bhatia Sushil8,Chakraborty Bhaswat9,Desai Nirav10,Modi Rajiv10,Shukla Chandreshwar10,Vachhani Kapil10,Patel Rashmi11,Kundu Anup12,Khamar Bakulesh10

Affiliation:

1. University of Iowa Hospitals and Clinics, Iowa City, USA

2. Post Graduate Institute of Medical Education & Research, Chandigarh, India

3. Dr. Ram Manohar Lohia Hospital & Post Graduate Institute of Medical Education and Research, New Delhi, India

4. Uro Care Hospital, Rajkot, India

5. Department of Urology, Lourdes Hospital, Kochi, India

6. Aarogyam Specialty Hospital, Ahmedabad, India

7. Saket City Hospital, New Delhi, India

8. Choithram Hospital & Research Centre, Indore, India

9. Institute of Pharmacy, Nirma University, Ahmedabad, India

10. Cadila Pharmaceuticals Limited, Ahmedabad, India

11. Institute Of Kidney Disease and Research Centre, Ahmedabad, India

12. The Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, India

Publisher

IOS Press

Subject

Urology,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3